The importance of minor salivary gland biopsy in prediction of lymphoma in Sjögren's syndrome: Should we be obtaining more information about prognosis from minor salivary gland samples?

Annals of the Rheumatic Diseases

Volumn 70, Issue 8, 2011, Pages 1351-1353

  Fox, Robert I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4; HOMING RECEPTOR;

B LYMPHOCYTE; CANCER RISK; DENDRITIC CELL; EDITORIAL; GERMINAL CENTER; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MALIGNANT TRANSFORMATION; MINOR SALIVA GLAND; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME;

FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME;

EID: 79959810575     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.152751     Document Type: Editorial

References (34)

1. Theander E. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011 ;70:1363-8.
2. Greenspan JS, Daniels TE, Talal N, et al. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974;37:217-29.
3. Adamson TC, 3rd, Fox RI, Frisman DM, et al. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol 1983;130:203-8. (Pubitemid 13172654)
4. Ramos-Casals M, Brito-Zeron P, Yagü J, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome. Rheumatology 2005;44:89.
5. Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003;48:3187-201. (Pubitemid 37409331)
6. Jonsson MV, Szodoray P, Jellestad S, et al. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome. J Clin Immunol 2005;25:189-201. (Pubitemid 40884044)
7. Jonsson MV, Skarstein K, Jonsson R, et al. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol 2007;34:2044-9. (Pubitemid 47548208)
8. Reksten TR, Jonsson MV, Szyszko EA, et al. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford) 2009;48:1102-6.
9. Jonsson MV, Skarstein K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome. J Oral Pathol Med 2008;37:515-21.
10. Stott DI, Hiepe F, Hummel M, et al. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998;102:938-46. (Pubitemid 28419239)
11. Hjelmervik TO, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52:1534-44. (Pubitemid 40663945)
12. Hansen A, Lipsky PE, Dörner T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007;9:218.
13. Daridon C, Pers JO, Devauchelle V, et al. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2006;54:2280-8. (Pubitemid 44051085)
14. Larsson A, Bredberg A, Henriksson G, et al. Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects. Scand J Immunol 2005;61:98-107. (Pubitemid 40188354)
15. Jonsson R, Nginamau E, Szyszko E, et al. Role of B cells in Sjögren's syndrome-from benign lymphoproliferation to overt malignancy. Front Biosci 2007;12:2159-70.
16. Voulgarelis M, Dafni UG, Isenberg DA, et al. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-72. (Pubitemid 30263648)
17. Fox RI, Carstens SA, Fong S, et al. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. Arthritis Rheum 1982;25:419-26. (Pubitemid 12158951)
18. Konttinen YT, Sorsa T, Hukkanen M, et al. Topology of innervation of labial salivary glands by protein gene product 9.5 and synaptophysin immunoreactive nerves in patients with Sjögren's syndrome. J Rheumatol 1992;19:30-7.
19. Sutcliffe N, Inanc M, Speight P, et al. Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 1998;28:80-7. (Pubitemid 28480892)
20. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50:1262-9. (Pubitemid 38480838)
21. Kassan S, Talal N. Sjögren's syndrome with systemic lupus erythematosus/mixed connective tissue disease. In: Talal N, Moutsopoulos HM, Kassan SS, eds. Sjögren's Syndrome: Clinical and Immunological Aspects. Berlin:Springer Verlag, 1987:177-81.
22. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006;98:51-60. (Pubitemid 43057092)
23. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7. (Pubitemid 34214255)
24. Brito-Zerón P, Ramos-Casals M, Nardi N, et al. Circulating monoclonal immunoglobulins in Sjögren syndrome: prevalence and clinical significance in 237 patients. Medicine (Baltimore) 2005;84:90-7. (Pubitemid 40418637)
25. Brito-Zerón P, Ramos-Casals M, Bove A, et al. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology (Oxford) 2007;46:1359-62. (Pubitemid 47244514)
26. Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803. (Pubitemid 43799181)
27. Dogan A, Du M, Koulis A, et al. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 1997;151:1361-9. (Pubitemid 27479766)
28. Drillenburg P, van der Voort R, Koopman G, et al. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. A m J Pathol 1997;150:919-27. (Pubitemid 27106164)
29. Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005;11:3349-52. (Pubitemid 40627886)
30. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005;206:32-63. (Pubitemid 41105162)
31. Martin T, Weber JC, Levallois H, et al. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum 2000;43:908-16.
32. Mariette X. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 2001;60:1007-10. (Pubitemid 32989171)
33. Bende RJ, Aarts WM, Riedl RG, et al. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 2005;201:1229-41. (Pubitemid 40629067)
34. Bende RJ, van Maldegem F, van Noesel CJ. Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas. Haematologica 2009;94:1109-23.